| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Casamento Charles J is a Director at ETON with holdings across 4 companies. Recent SEC Form 4 filings include 1 buy and 19 sells.
Estimated insider holdings value: $2.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2024 | RLMD Relmada Therapeutics, Inc. | Director | Buy | 13,000 | $2.56 | $33,280.00 | New | -82.8% | -44.1% | |
| Sep 15, 2023 | GRDX Gridai Technologies Corp. | Director | Sell | 10 | $0.43 | $4.30 | -0.2% | -42.0% | -96.0% | |
| Aug 31, 2023 | GRDX Gridai Technologies Corp. | Director | Sell | 6,053 | $0.30 | $1,815.90 | -49.8% | -22.6% | -93.4% | |
| Apr 1, 2022 | RLMD Relmada Therapeutics, Inc. | Director | Sale+OE | 19,800 | $29.00 | $574,200.00 | -28.6% | -35.4% | -92.3% | |
| Sep 22, 2021 | RLMD Relmada Therapeutics, Inc. | Director | Sale+OE | 6,600 | $29.00 | $191,400.00 | -15.5% | -27.2% | +6.1% | |
| Jul 15, 2021 | RLMD Relmada Therapeutics, Inc. | Director | Sell | 3,300 | $31.54 | $104,088.34 | -23.8% | -20.9% | -28.8% | |
| Jun 1, 2021 | RLMD Relmada Therapeutics, Inc. | Director | Sell | 3,000 | $33.34 | $100,020.30 | -15.5% | -26.3% | -44.0% | |
| May 3, 2021 | RLMD Relmada Therapeutics, Inc. | Director | Sell | 3,000 | $38.22 | $114,647.10 | -23.2% | -32.7% | -34.5% | |
| Apr 1, 2021 | RLMD Relmada Therapeutics, Inc. | Director | Sell | 3,000 | $35.43 | $106,280.94 | -9.8% | -12.7% | -19.8% | |
| Mar 1, 2021 | RLMD Relmada Therapeutics, Inc. | Director | Sell | 3,000 | $33.87 | $101,617.80 | -15.8% | - | - |